BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 30850635)

  • 1. Fusion proteins consisting of Bet v 1 and Phl p 5 form IgE-reactive aggregates with reduced allergenic activity.
    Najafi N; Hofer G; Gattinger P; Smiljkovic D; Blatt K; Selb R; Stoecklinger A; Keller W; Valent P; Niederberger V; Thalhamer J; Valenta R; Flicker S
    Sci Rep; 2019 Mar; 9(1):4006. PubMed ID: 30850635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K; Breyer I; Focke-Tejkl M; Blatt K; Shamji MH; Layhadi J; Gieras A; Swoboda I; Zafred D; Keller W; Valent P; Durham SR; Valenta R
    J Immunol; 2013 Apr; 190(7):3068-78. PubMed ID: 23440415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgE antibodies to recombinant pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Bet v 2) account for a high percentage of grass pollen-specific IgE.
    Niederberger V; Laffer S; Fröschl R; Kraft D; Rumpold H; Kapiotis S; Valenta R; Spitzauer S
    J Allergy Clin Immunol; 1998 Feb; 101(2 Pt 1):258-64. PubMed ID: 9500760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity.
    Flicker S; Steinberger P; Ball T; Krauth MT; Verdino P; Valent P; Almo S; Valenta R
    J Allergy Clin Immunol; 2006 Jun; 117(6):1336-43. PubMed ID: 16750995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple independent IgE epitopes on the highly allergenic grass pollen allergen Phl p 5.
    Levin M; Rotthus S; Wendel S; Najafi N; Källström E; Focke-Tejkl M; Valenta R; Flicker S; Ohlin M
    Clin Exp Allergy; 2014 Nov; 44(11):1409-19. PubMed ID: 25262820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell epitope-containing hypoallergenic recombinant fragments of the major birch pollen allergen, Bet v 1, induce blocking antibodies.
    Vrtala S; Akdis CA; Budak F; Akdis M; Blaser K; Kraft D; Valenta R
    J Immunol; 2000 Dec; 165(11):6653-9. PubMed ID: 11086111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant monoclonal human immunoglobulin E to investigate the allergenic activity of major grass pollen allergen Phl p 5.
    Madritsch C; Flicker S; Scheiblhofer S; Zafred D; Pavkov-Keller T; Thalhamer J; Keller W; Valenta R
    Clin Exp Allergy; 2011 Feb; 41(2):270-80. PubMed ID: 21143538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: molecular, immunological, and structural characterization of the epitope-containing domain.
    Flicker S; Vrtala S; Steinberger P; Vangelista L; Bufe A; Petersen A; Ghannadan M; Sperr WR; Valent P; Norderhaug L; Bohle B; Stockinger H; Suphioglu C; Ong EK; Kraft D; Valenta R
    J Immunol; 2000 Oct; 165(7):3849-59. PubMed ID: 11034391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
    Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
    Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant marker allergens in diagnosis of patients with allergic rhinoconjunctivitis to tree and grass pollens.
    Canis M; Gröger M; Becker S; Klemens C; Kramer MF
    Am J Rhinol Allergy; 2011; 25(1):36-9. PubMed ID: 21711974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epitope specificity determines cross-protection of a SIT-induced IgG4 antibody.
    Gadermaier E; James LK; Shamji MH; Blatt K; Fauland K; Zieglmayer P; Garmatiuk T; Focke-Tejkl M; Villalba M; Beavil R; Keller W; Valent P; Durham SR; Gould HJ; Flicker S; Valenta R
    Allergy; 2016 Jan; 71(1):36-46. PubMed ID: 26221749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergens from birch pollen and pollen of the European chestnut share common epitopes.
    Hirschwehr R; Jäger S; Horak F; Ferreira F; Valenta R; Ebner C; Kraft D; Scheiner O
    Clin Exp Allergy; 1993 Sep; 23(9):755-61. PubMed ID: 10779306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of allergenic activity of the major grass pollen allergen Phl p 2 by reassembly as a mosaic protein.
    Mothes-Luksch N; Stumvoll S; Linhart B; Focke M; Krauth MT; Hauswirth A; Valent P; Verdino P; Pavkov T; Keller W; Grote M; Valenta R
    J Immunol; 2008 Oct; 181(7):4864-73. PubMed ID: 18802090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of an allergy vaccine by disruption of the three-dimensional structure of the cross-reactive calcium-binding allergen, Phl p 7.
    Westritschnig K; Focke M; Verdino P; Goessler W; Keller W; Twardosz A; Mari A; Horak F; Wiedermann U; Hartl A; Thalhamer J; Sperr WR; Valent P; Valenta R
    J Immunol; 2004 May; 172(9):5684-92. PubMed ID: 15100313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of specific IgE antibodies in sera of Japanese birch-allergic patients using recombinant allergens Bet v 1, Bet v 2 and Bet v 4.
    Shirasaki H; Yamamoto T; Koyanagi Y; Watanabe N; Himi T
    Allergol Int; 2008 Mar; 57(1):93-6. PubMed ID: 18209509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonanaphylactic synthetic peptides derived from B cell epitopes of the major grass pollen allergen, Phl p 1, for allergy vaccination.
    Focke M; Mahler V; Ball T; Sperr WR; Majlesi Y; Valent P; Kraft D; Valenta R
    FASEB J; 2001 Sep; 15(11):2042-4. PubMed ID: 11511525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.